Page last updated: 2024-11-05

1,2,3,4-tetrahydroisoquinoline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,2,3,4-tetrahydroisoquinoline is a heterocyclic compound that is the parent structure of a wide range of bioactive molecules. Its synthesis can be achieved through various methods, including the Bischler-Napieralski reaction and the Pictet-Spengler reaction. It exhibits a range of pharmacological effects, including anti-inflammatory, analgesic, and anticonvulsant activities. Its importance lies in its structural similarity to neurotransmitters like dopamine and its potential to modulate their activity. It is studied extensively as a scaffold for the development of new drugs for various neurological and psychiatric conditions. Research focuses on exploring its therapeutic potential and understanding its interactions with various biological targets.'

1,2,3,4-tetrahydroisoquinoline: RN given refers to cpd with locants as specified [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID7046
CHEMBL ID14346
CHEBI ID125498
SCHEMBL ID19085
MeSH IDM0063662

Synonyms (68)

Synonym
1,3,4-tetrahydroisoquinoline
tetrahydroisoquinoline
nsc-15312
nsc15312
91-21-4
wln: t66 cmt&j
inchi=1/c9h11n/c1-2-4-9-7-10-6-5-8(9)3-1/h1-4,10h,5-7h
isoquinoline, 1,2,3,4-tetrahydro-
1,2,3,4-tetrahydroisoquinoline
NCGC00091283-01
1,2,3,4-tetrahydro isoquinoline
brn 0116156
einecs 202-050-0
ai3-15931
nsc 15312
1,2,3,4-tetrahydroisoquinoline, 95%
3,4-dihydro-1h-isoquinoline
1,2,3,4-tetrahydro-2-azanaphthalene
chembl14346 ,
bdbm13016
thiq 6
CHEBI:125498
1,2,3,4-tetrahydro-isoquinoline
L001004
T1676
AKOS000119066
NCGC00091283-02
tetrahydro-isoquinoline
cas-91-21-4
tox21_200374
NCGC00257928-01
dtxcid106115
dtxsid6026115 ,
unii-56w89fbx3e
56w89fbx3e ,
ec 202-050-0
5-20-06-00320 (beilstein handbook reference)
FT-0600443
BRD-K18436203-001-01-4
2ck ,
SCHEMBL19085
racemic tetrahydroisoquinoline
tetrahyroisoquinoline
1, 2, 3, 4-tetrahydro-isoquinoline
1,2,3,4-tetra-hydroisoquinoline
1,2,3,4-tetrahydro-2-isoquinoline
1,2,3,4 tetrahydroisoquinoline
1,2,3,4-tetrahydroisochinoline
1,2,3,4,-tetrahydro-isoquinoline
1, 2, 3, 4-tetrahydroisoquinoline
1, 2, 3, 4 tetrahydroisoquinoline
1,2.3.4-tetrahydroisoquinoline
3,4-dihydro-1 h-isoquinoline
1,2,3,4- tetrahydroisoquinoline
W-100315
TS-01726
Q-102336
Z57834231
mfcd00006896
1,2,3,4-?tetrahydroisoquinoline
F2190-0352
CS-W002013
1,2,3,4-tetrahydroleucoline
SY001156
Q411677
STL182848
1 pound not2 pound not3 pound not4-tetrahydro-isoquinoline
EN300-18301

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Nine isoquinolines and MPP(+) showed general cytotoxicity in both parental cell lines after 72hr with half-maximal toxic concentrations (TC(50) values) in the micromolar range."( Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: studies using heterologous expression systems of the dopamine transporter.
Frenzel, S; Hein, A; Hwang, YI; Matsubara, K; Ohta, S; Ortmann, R; Ott, S; Schwarz, J; Storch, A; Wolf, HU, 2002
)
0.31
" Both SAL and THP were well tolerated up to roughly 30 microM and became overtly toxic at higher concentrations, with SAL being better tolerated than THP."( Cytotoxicity of dopamine-derived tetrahydroisoquinolines on melanoma cells.
Blarzino, C; Coccia, R; De Marco, F; Foppoli, C; Marcante, ML; Perluigi, M; Rosei, MA, 2002
)
0.31

Dosage Studied

ExcerptRelevanceReference
" A significant reduction of the ligand-DATs binding was found in the mice treated with MPTP, but not with TIQ, under the dosage inducing behavioral abnormality and loss of tyrosine hydroxylase-positive cells in the substantia nigra."( Evaluation of neurotoxicity of TIQ and MPTP and of parkinsonism-preventing effect of 1-MeTIQ by in vivo measurement of pre-synaptic dopamine transporters and post-synaptic dopamine D(2) receptors in the mouse striatum.
Abe, K; Ishiwata, K; Kawamura, K; Koyanagi, Y; Saitoh, T; Sano, T; Senda, M; Taguchi, K; Toda, J, 2001
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
isoquinolinesA class of organic heteropolycyclic compound consisting of isoquinoline and its substitution derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (16)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency70.33710.000714.592883.7951AID1259369
AR proteinHomo sapiens (human)Potency55.87070.000221.22318,912.5098AID1259243
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency3.95530.003041.611522,387.1992AID1159552
estrogen nuclear receptor alphaHomo sapiens (human)Potency7.94330.000229.305416,493.5996AID588513
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency0.39910.001019.414170.9645AID743094
aryl hydrocarbon receptorHomo sapiens (human)Potency31.41840.000723.06741,258.9301AID743085
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Phenylethanolamine N-methyltransferaseBos taurus (cattle)Ki8,527,416,670.08080.00312.329310.0000AID155135; AID155141; AID155144; AID155145; AID155146; AID155167; AID155172; AID155306; AID156052; AID156055; AID156064; AID313558
Phenylethanolamine N-methyltransferaseHomo sapiens (human)Ki8.10000.00161.35296.9000AID155320; AID1796978; AID271160; AID293029
Alpha-2B adrenergic receptorRattus norvegicus (Norway rat)Ki281,837,987,430.71510.00000.929610.0000AID271161; AID293030; AID35193; AID35195; AID35395; AID37364; AID37379; AID37385
Amine oxidase [flavin-containing] AHomo sapiens (human)Ki210.00000.00192.379710.0000AID125554
Alpha-2C adrenergic receptorRattus norvegicus (Norway rat)Ki281,837,987,430.71500.00000.970810.0000AID271161; AID293030; AID35193; AID35195; AID35395; AID37364; AID37379; AID37385
Alpha-2A adrenergic receptorRattus norvegicus (Norway rat)Ki281,837,987,430.71500.00000.937510.0000AID271161; AID293030; AID35193; AID35195; AID35395; AID37364; AID37379; AID37385
Amine oxidase [flavin-containing] BHomo sapiens (human)Ki15.00000.00061.777110.0000AID126534
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (46)

Processvia Protein(s)Taxonomy
methylationPhenylethanolamine N-methyltransferaseBos taurus (cattle)
epinephrine biosynthetic processPhenylethanolamine N-methyltransferaseBos taurus (cattle)
methylationPhenylethanolamine N-methyltransferaseHomo sapiens (human)
epinephrine biosynthetic processPhenylethanolamine N-methyltransferaseHomo sapiens (human)
catecholamine biosynthetic processPhenylethanolamine N-methyltransferaseHomo sapiens (human)
cell adhesionCD44 antigenHomo sapiens (human)
cell-matrix adhesionCD44 antigenHomo sapiens (human)
cell migrationCD44 antigenHomo sapiens (human)
cytokine-mediated signaling pathwayCD44 antigenHomo sapiens (human)
hyaluronan catabolic processCD44 antigenHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationCD44 antigenHomo sapiens (human)
positive regulation of heterotypic cell-cell adhesionCD44 antigenHomo sapiens (human)
T cell activationCD44 antigenHomo sapiens (human)
negative regulation of apoptotic processCD44 antigenHomo sapiens (human)
negative regulation of cysteine-type endopeptidase activity involved in apoptotic processCD44 antigenHomo sapiens (human)
negative regulation of DNA damage response, signal transduction by p53 class mediatorCD44 antigenHomo sapiens (human)
wound healing, spreading of cellsCD44 antigenHomo sapiens (human)
cellular response to fibroblast growth factor stimulusCD44 antigenHomo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCD44 antigenHomo sapiens (human)
cartilage developmentCD44 antigenHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeCD44 antigenHomo sapiens (human)
monocyte aggregationCD44 antigenHomo sapiens (human)
cell-cell adhesionCD44 antigenHomo sapiens (human)
positive regulation of monocyte aggregationCD44 antigenHomo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCD44 antigenHomo sapiens (human)
regulation of lamellipodium morphogenesisCD44 antigenHomo sapiens (human)
inflammatory responseCD44 antigenHomo sapiens (human)
biogenic amine metabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
positive regulation of signal transductionAmine oxidase [flavin-containing] AHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
response to xenobiotic stimulusAmine oxidase [flavin-containing] BHomo sapiens (human)
response to toxic substanceAmine oxidase [flavin-containing] BHomo sapiens (human)
response to aluminum ionAmine oxidase [flavin-containing] BHomo sapiens (human)
response to selenium ionAmine oxidase [flavin-containing] BHomo sapiens (human)
negative regulation of serotonin secretionAmine oxidase [flavin-containing] BHomo sapiens (human)
phenylethylamine catabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
substantia nigra developmentAmine oxidase [flavin-containing] BHomo sapiens (human)
response to lipopolysaccharideAmine oxidase [flavin-containing] BHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
response to ethanolAmine oxidase [flavin-containing] BHomo sapiens (human)
positive regulation of dopamine metabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
hydrogen peroxide biosynthetic processAmine oxidase [flavin-containing] BHomo sapiens (human)
response to corticosteroneAmine oxidase [flavin-containing] BHomo sapiens (human)
nicotinamide metabolic processNicotinamide N-methyltransferaseHomo sapiens (human)
response to xenobiotic stimulusNicotinamide N-methyltransferaseHomo sapiens (human)
response to organonitrogen compoundNicotinamide N-methyltransferaseHomo sapiens (human)
animal organ regenerationNicotinamide N-methyltransferaseHomo sapiens (human)
methylationNicotinamide N-methyltransferaseHomo sapiens (human)
NAD biosynthesis via nicotinamide riboside salvage pathwayNicotinamide N-methyltransferaseHomo sapiens (human)
positive regulation of gluconeogenesisNicotinamide N-methyltransferaseHomo sapiens (human)
positive regulation of protein deacetylationNicotinamide N-methyltransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (14)

Processvia Protein(s)Taxonomy
phenylethanolamine N-methyltransferase activityPhenylethanolamine N-methyltransferaseBos taurus (cattle)
phenylethanolamine N-methyltransferase activityPhenylethanolamine N-methyltransferaseHomo sapiens (human)
protein bindingPhenylethanolamine N-methyltransferaseHomo sapiens (human)
cytokine receptor activityCD44 antigenHomo sapiens (human)
protein bindingCD44 antigenHomo sapiens (human)
collagen bindingCD44 antigenHomo sapiens (human)
hyaluronic acid bindingCD44 antigenHomo sapiens (human)
transmembrane signaling receptor activityCD44 antigenHomo sapiens (human)
protein bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
protein bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
electron transfer activityAmine oxidase [flavin-containing] BHomo sapiens (human)
identical protein bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
nicotinamide N-methyltransferase activityNicotinamide N-methyltransferaseHomo sapiens (human)
pyridine N-methyltransferase activityNicotinamide N-methyltransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (18)

Processvia Protein(s)Taxonomy
cytosolPhenylethanolamine N-methyltransferaseHomo sapiens (human)
cytosolPhenylethanolamine N-methyltransferaseHomo sapiens (human)
Golgi apparatusCD44 antigenHomo sapiens (human)
cytosolCD44 antigenHomo sapiens (human)
plasma membraneCD44 antigenHomo sapiens (human)
microvillusCD44 antigenHomo sapiens (human)
focal adhesionCD44 antigenHomo sapiens (human)
cell surfaceCD44 antigenHomo sapiens (human)
apical plasma membraneCD44 antigenHomo sapiens (human)
secretory granule membraneCD44 antigenHomo sapiens (human)
lamellipodium membraneCD44 antigenHomo sapiens (human)
cell projectionCD44 antigenHomo sapiens (human)
extracellular exosomeCD44 antigenHomo sapiens (human)
macrophage migration inhibitory factor receptor complexCD44 antigenHomo sapiens (human)
basolateral plasma membraneCD44 antigenHomo sapiens (human)
plasma membraneCD44 antigenHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] AHomo sapiens (human)
cytosolAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrial envelopeAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] BHomo sapiens (human)
dendriteAmine oxidase [flavin-containing] BHomo sapiens (human)
neuronal cell bodyAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] BHomo sapiens (human)
cytosolNicotinamide N-methyltransferaseHomo sapiens (human)
cytosolNicotinamide N-methyltransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (55)

Assay IDTitleYearJournalArticle
AID4015Binding affinity towards 5-hydroxytryptamine 1A receptor in the rat brain (hippocampus) using [3H]8-OH-DPAT1996Journal of medicinal chemistry, Mar-01, Volume: 39, Issue:5
8-[4-[2-(1,2,3,4-Tetrahydroisoquinolinyl]butyl-8-azaspiro[4.5]decane-7,9-dione: a new 5-HT1A receptor ligand with the same activity profile as buspirone.
AID156064Inhibitory activity against bovine adrenal phenylethanolamine N-methyl-transferase (PNMT)1999Bioorganic & medicinal chemistry letters, Feb-08, Volume: 9, Issue:3
Comparative molecular field analysis (CoMFA) models of phenylethanolamine N-methyltransferase (PNMT) and the alpha2-adrenoceptor: the development of new, highly selective inhibitors of PNMT.
AID37364In vitro for binding affinity against Alpha-2 adrenergic receptor by radioligand [3H]clonidine in rat1996Journal of medicinal chemistry, Aug-30, Volume: 39, Issue:18
Effect of ring size or an additional heteroatom on the potency and selectivity of bicyclic benzylamine-type inhibitors of phenylethanolamine N-methyltransferase.
AID156055In vitro inhibition of bovine phenylethylamine N-methyl-transferase (PNMT) using radiochemical assay.1987Journal of medicinal chemistry, Dec, Volume: 30, Issue:12
Inhibition of phenylethanolamine N-methyltransferase (PNMT) by aromatic hydroxy-substituted 1,2,3,4,-tetrahydroisoquinolines: further studies on the hydrophilic pocket of the aromatic ring binding region of the active site.
AID313560Selectivity of Ki for bovine PNMT over Ki for rat alpha-2 adrenoceptor2008Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
Synthesis of 4,5,6,7-tetrahydrothieno[3,2-c]pyridines and comparison with their isosteric 1,2,3,4-tetrahydroisoquinolines as inhibitors of phenylethanolamine N-methyltransferase.
AID61002The maximum dopamine release induced by perfusion with the test compound with basal striatal DA (%of basal x10E-3)1990Journal of medicinal chemistry, Aug, Volume: 33, Issue:8
In vivo intracerebral microdialysis studies in rats of MPP+ analogues and related charged species.
AID722233Inhibition of melanogenesis in mouse B16-4A5 cells at 1 uM after 72 hrs by spectrophotometry2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Alkaloid constituents from flower buds and leaves of sacred lotus (Nelumbo nucifera, Nymphaeaceae) with melanogenesis inhibitory activity in B16 melanoma cells.
AID293029Binding affinity to human PNMT2007Bioorganic & medicinal chemistry, Feb-01, Volume: 15, Issue:3
Exploring the active site of phenylethanolamine N-methyltransferase with 1,2,3,4-tetrahydrobenz[h]isoquinoline inhibitors.
AID233048Binding selectivity against PNMT and alpha-2-adrenoceptors, measured as the ratio of the respective in vitro Ki's.1999Journal of medicinal chemistry, Jan-14, Volume: 42, Issue:1
Synthesis, biochemical evaluation, and classical and three-dimensional quantitative structure-activity relationship studies of 7-substituted-1,2,3,4-tetrahydroisoquinolines and their relative affinities toward phenylethanolamine N-methyltransferase and th
AID721318Cytotoxicity against mouse B16-4A5 cells assessed as cell viability at 30 uM after 70 hrs by WST-8 assay2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Alkaloid constituents from flower buds and leaves of sacred lotus (Nelumbo nucifera, Nymphaeaceae) with melanogenesis inhibitory activity in B16 melanoma cells.
AID271162Selectivity for human PNMT over rat Adrenergic alpha-2 receptor2006Journal of medicinal chemistry, Sep-07, Volume: 49, Issue:18
Comparison of the binding of 3-fluoromethyl-7-sulfonyl-1,2,3,4-tetrahydroisoquinolines with their isosteric sulfonamides to the active site of phenylethanolamine N-methyltransferase.
AID1367487Lipophilicity, log P of the compound2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Improvement in aqueous solubility achieved via small molecular changes.
AID229906Selectivity ratio between Ki of alpha-2 adrenoceptor and Ki of PNMT1996Journal of medicinal chemistry, Aug-30, Volume: 39, Issue:18
Effect of ring size or an additional heteroatom on the potency and selectivity of bicyclic benzylamine-type inhibitors of phenylethanolamine N-methyltransferase.
AID271160Binding affinity to human PNMT expressed in Escherichia coli by radiochemical assay2006Journal of medicinal chemistry, Sep-07, Volume: 49, Issue:18
Comparison of the binding of 3-fluoromethyl-7-sulfonyl-1,2,3,4-tetrahydroisoquinolines with their isosteric sulfonamides to the active site of phenylethanolamine N-methyltransferase.
AID35335Selectivity determined by Ki of alpha 2 receptor / Ki of PNMT1999Journal of medicinal chemistry, Aug-26, Volume: 42, Issue:17
Synthesis and evaluation of 3-trifluoromethyl-7-substituted-1,2,3, 4-tetrahydroisoquinolines as selective inhibitors of phenylethanolamine N-methyltransferase versus the alpha(2)-adrenoceptor.
AID155146Inhibition of PNMT (Phenylethanolamine N-Methyltransferase) in vitro 1999Journal of medicinal chemistry, Aug-26, Volume: 42, Issue:17
Synthesis and evaluation of 3-trifluoromethyl-7-substituted-1,2,3, 4-tetrahydroisoquinolines as selective inhibitors of phenylethanolamine N-methyltransferase versus the alpha(2)-adrenoceptor.
AID155329Inhibition of phenylethanolamine N-methyl-transferase from rabbit adrenal gland at 10e-6 M1980Journal of medicinal chemistry, May, Volume: 23, Issue:5
Inhibitors of phenylethanolamine N-methyltransferase and epinephrine biosynthesis. 1. Chloro-substituted 1,2,3,4-tetrahydroisoquinolines.
AID271161Displacement of [3H]clonidine from Sprague-Dawley rat cortex adrenergic alpha 2 receptor2006Journal of medicinal chemistry, Sep-07, Volume: 49, Issue:18
Comparison of the binding of 3-fluoromethyl-7-sulfonyl-1,2,3,4-tetrahydroisoquinolines with their isosteric sulfonamides to the active site of phenylethanolamine N-methyltransferase.
AID721321Inhibition of melanogenesis in mouse B16-4A5 cells at 30 uM after 72 hrs by spectrophotometry2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Alkaloid constituents from flower buds and leaves of sacred lotus (Nelumbo nucifera, Nymphaeaceae) with melanogenesis inhibitory activity in B16 melanoma cells.
AID126534Compounds were tested for inhibition against human liver Monoamine oxidase B (competitive inhibition was observed)1990Journal of medicinal chemistry, Jan, Volume: 33, Issue:1
Inhibition of monoamine oxidases A and B by simple isoquinoline alkaloids: racemic and optically active 1,2,3,4-tetrahydro-, 3,4-dihydro-, and fully aromatic isoquinolines.
AID155306Inhibitory constant against bovine phenylethanolamine N-methyl-transferase2001Bioorganic & medicinal chemistry letters, Jun-18, Volume: 11, Issue:12
Phenylethanolamine N-methyltransferase kinetics: bovine versus recombinant human enzyme.
AID155172Inhibition of phenylethanolamine N-methyl-transferase (PNMT)1988Journal of medicinal chemistry, Feb, Volume: 31, Issue:2
Conformational and steric aspects of the inhibition of phenylethanolamine N-methyltransferase by benzylamines.
AID1129495Binding affinity to immobilized recombinant mouse CD44 hyaluronan binding domain by surface plasmon resonance assay2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
Fragment-based identification of an inducible binding site on cell surface receptor CD44 for the design of protein-carbohydrate interaction inhibitors.
AID125554Inhibition of human placental Monoamine oxidase A (competitive inhibition was observed)1990Journal of medicinal chemistry, Jan, Volume: 33, Issue:1
Inhibition of monoamine oxidases A and B by simple isoquinoline alkaloids: racemic and optically active 1,2,3,4-tetrahydro-, 3,4-dihydro-, and fully aromatic isoquinolines.
AID313559Displacement of [3H]clonidine from adrenergic alpha-1 receptor in Sprague-Dawley rat cortex2008Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
Synthesis of 4,5,6,7-tetrahydrothieno[3,2-c]pyridines and comparison with their isosteric 1,2,3,4-tetrahydroisoquinolines as inhibitors of phenylethanolamine N-methyltransferase.
AID37385In vitro inhibitory activity against alpha-2 adrenergic receptor using [3H]clonidine as radioligand in male Sprague-Dawley rats1999Journal of medicinal chemistry, Jan-14, Volume: 42, Issue:1
Synthesis, biochemical evaluation, and classical and three-dimensional quantitative structure-activity relationship studies of 7-substituted-1,2,3,4-tetrahydroisoquinolines and their relative affinities toward phenylethanolamine N-methyltransferase and th
AID61001The maximal DA release induced by perfusion with 10 mM MPP+ (15 min) 1 day after perfusion with the test compound with basal striatal DA (%of basal x10E-3)1990Journal of medicinal chemistry, Aug, Volume: 33, Issue:8
In vivo intracerebral microdialysis studies in rats of MPP+ analogues and related charged species.
AID155141In vitro inhibitory activity against bovine adrenal phenylethanolamine N-methyl transferase1999Journal of medicinal chemistry, Jun-03, Volume: 42, Issue:11
3,7-Disubstituted-1,2,3,4-tetrahydroisoquinolines display remarkable potency and selectivity as inhibitors of phenylethanolamine N-methyltransferase versus the alpha2-adrenoceptor.
AID721322Inhibition of melanogenesis in mouse B16-4A5 cells at 10 uM after 72 hrs by spectrophotometry2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Alkaloid constituents from flower buds and leaves of sacred lotus (Nelumbo nucifera, Nymphaeaceae) with melanogenesis inhibitory activity in B16 melanoma cells.
AID1129494Binding affinity to immobilized recombinant human CD44 hyaluronan binding domain by surface plasmon resonance assay2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
Fragment-based identification of an inducible binding site on cell surface receptor CD44 for the design of protein-carbohydrate interaction inhibitors.
AID155167In vitro inhibitory activity measured against bovine adrenal phenylethanolamine N-methyltransferase(PNMT)1988Journal of medicinal chemistry, Apr, Volume: 31, Issue:4
Synthesis and evaluation of 3-substituted analogues of 1,2,3,4-tetrahydroisoquinoline as inhibitors of phenylethanolamine N-methyltransferase.
AID37379In vitro binding affinity towards cortical membranes of male Sprague-Dawley rats alpha-2 adrenergic receptor by replacing [3H]clonidine1999Journal of medicinal chemistry, Jun-03, Volume: 42, Issue:11
3,7-Disubstituted-1,2,3,4-tetrahydroisoquinolines display remarkable potency and selectivity as inhibitors of phenylethanolamine N-methyltransferase versus the alpha2-adrenoceptor.
AID155135In vitro for inhibition of Phenylethanolamine N-Methyltransferase (PNMT)1996Journal of medicinal chemistry, Aug-30, Volume: 39, Issue:18
Effect of ring size or an additional heteroatom on the potency and selectivity of bicyclic benzylamine-type inhibitors of phenylethanolamine N-methyltransferase.
AID155320Inhibitory constant against human phenylethanolamine N-methyl-transferase over-expressed in Escherichia coli2001Bioorganic & medicinal chemistry letters, Jun-18, Volume: 11, Issue:12
Phenylethanolamine N-methyltransferase kinetics: bovine versus recombinant human enzyme.
AID155337Ki ratio of human versus bovine phenylethanolamine N-methyl-transferase2001Bioorganic & medicinal chemistry letters, Jun-18, Volume: 11, Issue:12
Phenylethanolamine N-methyltransferase kinetics: bovine versus recombinant human enzyme.
AID722232Inhibition of melanogenesis in mouse B16-4A5 cells at 3 uM after 72 hrs by spectrophotometry2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Alkaloid constituents from flower buds and leaves of sacred lotus (Nelumbo nucifera, Nymphaeaceae) with melanogenesis inhibitory activity in B16 melanoma cells.
AID35195In vitro inhibition of [3H]clonidine binding at the alpha-2 adrenergic receptor.1999Journal of medicinal chemistry, Oct-21, Volume: 42, Issue:21
Enantiospecific synthesis of 3-fluoromethyl-, 3-hydroxymethyl-, and 3-chloromethyl-1,2,3,4-tetrahydroisoquinolines as selective inhibitors of phenylethanolamine N-methyltransferase versus the alpha(2)-adrenoceptor.
AID313558Inhibition of bovine PNMT by radiochemical assay2008Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
Synthesis of 4,5,6,7-tetrahydrothieno[3,2-c]pyridines and comparison with their isosteric 1,2,3,4-tetrahydroisoquinolines as inhibitors of phenylethanolamine N-methyltransferase.
AID293031Selectivity for human PNMT over Sprague-Dawley rat adrenergic alpha-2 receptor2007Bioorganic & medicinal chemistry, Feb-01, Volume: 15, Issue:3
Exploring the active site of phenylethanolamine N-methyltransferase with 1,2,3,4-tetrahydrobenz[h]isoquinoline inhibitors.
AID156052Binding affinity to phenylethanolamine N-methyltransferase(PNMT) in bovine1988Journal of medicinal chemistry, Jan, Volume: 31, Issue:1
Conformational requirements of substrates for activity with phenylethanolamine N-methyltransferase.
AID155144In vitro inhibitory activity against bovine adrenal phenylethanolamine N-methyltransferase(PNMT)1999Journal of medicinal chemistry, Jan-14, Volume: 42, Issue:1
Synthesis, biochemical evaluation, and classical and three-dimensional quantitative structure-activity relationship studies of 7-substituted-1,2,3,4-tetrahydroisoquinolines and their relative affinities toward phenylethanolamine N-methyltransferase and th
AID35193The compound was tested in vitro for binding affinity against Alpha-2 adrenergic receptor using [3H]clonidine1999Journal of medicinal chemistry, Aug-26, Volume: 42, Issue:17
Synthesis and evaluation of 3-trifluoromethyl-7-substituted-1,2,3, 4-tetrahydroisoquinolines as selective inhibitors of phenylethanolamine N-methyltransferase versus the alpha(2)-adrenoceptor.
AID155328Inhibition of phenylethanolamine N-methyl-transferase from rabbit adrenal gland at 10e-4 M1980Journal of medicinal chemistry, May, Volume: 23, Issue:5
Inhibitors of phenylethanolamine N-methyltransferase and epinephrine biosynthesis. 1. Chloro-substituted 1,2,3,4-tetrahydroisoquinolines.
AID155145In vitro inhibition of PNMT (Phenylethanolamine N-Methyltransferase).1999Journal of medicinal chemistry, Oct-21, Volume: 42, Issue:21
Enantiospecific synthesis of 3-fluoromethyl-, 3-hydroxymethyl-, and 3-chloromethyl-1,2,3,4-tetrahydroisoquinolines as selective inhibitors of phenylethanolamine N-methyltransferase versus the alpha(2)-adrenoceptor.
AID293030Displacement of [3H]clonidine from adrenergic alpha2 receptor in Sprague-Dawley rat cortex membrane2007Bioorganic & medicinal chemistry, Feb-01, Volume: 15, Issue:3
Exploring the active site of phenylethanolamine N-methyltransferase with 1,2,3,4-tetrahydrobenz[h]isoquinoline inhibitors.
AID721320Inhibition of melanogenesis in mouse B16-4A5 cells at 100 uM after 72 hrs by spectrophotometry2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Alkaloid constituents from flower buds and leaves of sacred lotus (Nelumbo nucifera, Nymphaeaceae) with melanogenesis inhibitory activity in B16 melanoma cells.
AID1129496Inhibition of recombinant human hyaluronan binding domain of CD44 binding to immobilized polymeric hyaluronan by surface plasmon resonance assay2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
Fragment-based identification of an inducible binding site on cell surface receptor CD44 for the design of protein-carbohydrate interaction inhibitors.
AID721317Cytotoxicity against mouse B16-4A5 cells assessed as cell viability at 100 uM after 70 hrs by WST-8 assay2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Alkaloid constituents from flower buds and leaves of sacred lotus (Nelumbo nucifera, Nymphaeaceae) with melanogenesis inhibitory activity in B16 melanoma cells.
AID172323Percentage of basal lactate efflux before starting the drug perfusion (150 min) with average basal level 689+/-103 pmol/min1990Journal of medicinal chemistry, Aug, Volume: 33, Issue:8
In vivo intracerebral microdialysis studies in rats of MPP+ analogues and related charged species.
AID233623Ratio of binding affinity of PNMT to alpha-2 receptors.1999Journal of medicinal chemistry, Oct-21, Volume: 42, Issue:21
Enantiospecific synthesis of 3-fluoromethyl-, 3-hydroxymethyl-, and 3-chloromethyl-1,2,3,4-tetrahydroisoquinolines as selective inhibitors of phenylethanolamine N-methyltransferase versus the alpha(2)-adrenoceptor.
AID35395Inhibition of [3H]clonidine binding to the rat alpha-2-adrenoceptor1999Bioorganic & medicinal chemistry letters, Feb-08, Volume: 9, Issue:3
Comparative molecular field analysis (CoMFA) models of phenylethanolamine N-methyltransferase (PNMT) and the alpha2-adrenoceptor: the development of new, highly selective inhibitors of PNMT.
AID1796978Radiochemical Assay of PNMT Inhibitors from Article 10.1021/jm060466d: \\Comparison of the binding of 3-fluoromethyl-7-sulfonyl-1,2,3,4-tetrahydroisoquinolines with their isosteric sulfonamides to the active site of phenylethanolamine N-methyltransferase.\\2006Journal of medicinal chemistry, Sep-07, Volume: 49, Issue:18
Comparison of the binding of 3-fluoromethyl-7-sulfonyl-1,2,3,4-tetrahydroisoquinolines with their isosteric sulfonamides to the active site of phenylethanolamine N-methyltransferase.
AID1802032NNMT Enzymatic Activity Assay from Article 10.1021/acs.biochem.6b00733: \\A Rapid and Efficient Assay for the Characterization of Substrates and Inhibitors of Nicotinamide N-Methyltransferase.\\2016Biochemistry, 09-20, Volume: 55, Issue:37
A Rapid and Efficient Assay for the Characterization of Substrates and Inhibitors of Nicotinamide N-Methyltransferase.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (229)

TimeframeStudies, This Drug (%)All Drugs %
pre-199061 (26.64)18.7374
1990's43 (18.78)18.2507
2000's42 (18.34)29.6817
2010's57 (24.89)24.3611
2020's26 (11.35)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.57

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.57 (24.57)
Research Supply Index5.48 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index44.85 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (31.57)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews20 (8.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other220 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]